A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy.
about
Endothelin receptor antagonists for pulmonary arterial hypertensionMicroenvironment-derived factors driving metastatic plasticity in melanoma.Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer.Role of the endothelin axis and its antagonists in the treatment of cancerSurrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trialsClinical Adverse Effects of Endothelin Receptor Antagonists: Insights From the Meta-Analysis of 4894 Patients From 24 Randomized Double-Blind Placebo-Controlled Clinical Trials.Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in MiceRendomab B4, a monoclonal antibody that discriminates the human endothelin B receptor of melanoma cells and inhibits their migration.Endothelins and their receptors in cancer: identification of therapeutic targets.Novel targets for VEGF-independent anti-angiogenic drugs.Molecular networks in melanoma invasion and metastasis.Association of oral endothelin receptor antagonists with risks of cardiovascular events and mortality: meta-analysis of randomized controlled trials.Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.Correlated expression levels of endothelin receptor B and Plexin C1 in melanoma.Dacarbazine combined targeted therapy versus dacarbazine alone in patients with malignant melanoma: a meta-analysis.[Malignant head and neck melanoma: Part 2: Therapy].
P2860
Q24200714-F4DF3F0D-8738-4C2C-AEB2-185F83F9E882Q30838636-BEA0305F-5485-473E-B70A-5500FB7EE7D1Q34551567-9600B108-2990-4D3A-9AD8-6E5D5A942408Q34919570-53914ED6-C2D6-4DE5-A29C-7362C0242A74Q35645254-FA8B8E12-8416-4C6F-9BC2-31C24570355DQ36212186-9FE0E706-E11E-4D91-B9E3-086A260BCB02Q36657607-BCBCF2C3-1448-4FFB-A562-8C57011C7B22Q37327310-5DB7C299-63B0-4BEE-B11B-42640D2624EEQ37830914-5194BFF8-84D6-46F0-8D9A-036D9F91F76CQ37984612-443D3750-C719-4054-A9C6-F741FBE62F34Q38104416-AC4535FE-F690-45F3-B4FE-6EBF4894B17FQ39106330-7E539745-EF01-4BB9-8316-7D048C3B396DQ39236911-45145CDA-0577-41F9-B735-FCA48B0D5054Q41414951-E69B0F6D-508E-4B3C-AD2C-9D19336E1C4AQ41696382-3FA03A8E-ED8A-4226-A7FA-2DF6EB8A3278Q54256327-4F9C2CC7-4B37-45D2-882E-C58C89E5D120
P2860
A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A randomized, double-blind, pl ...... line dacarbazine chemotherapy.
@ast
A randomized, double-blind, pl ...... line dacarbazine chemotherapy.
@en
type
label
A randomized, double-blind, pl ...... line dacarbazine chemotherapy.
@ast
A randomized, double-blind, pl ...... line dacarbazine chemotherapy.
@en
prefLabel
A randomized, double-blind, pl ...... line dacarbazine chemotherapy.
@ast
A randomized, double-blind, pl ...... line dacarbazine chemotherapy.
@en
P2093
P2860
P356
P1433
P1476
A randomized, double-blind, pl ...... line dacarbazine chemotherapy.
@en
P2093
Adele Morganti
Andrea Ballmer
Benjamin Brady
Peter Hersey
Philip R Clingan
Richard F Kefford
P2860
P2888
P356
10.1186/1476-4598-9-69
P577
2010-03-30T00:00:00Z
P5875
P6179
1009275071